Protein network analyses using these 21 proteins, as well as other associated proteins, suggested modulation of β-catenin (CTNNB1), NRF2 (NFE2L2), VEGFA, EGFR and MMP9, which are known AD- and/or dermatological condition-associated signaling molecules. This evidence concerns the gene EGFR and Alzheimer disease.